ENTITY
Hyphens Pharma International

Hyphens Pharma International (HYP SP)

32
Analysis
Health CareSingapore
Hyphens Pharma International Limited is Singapore’s leading specialty pharmaceutical and consumer healthcare group. It develops and owns several dermatological products and supplements, such as Ceradan, TDF and Ocean Health. The Group also markets and sells specialty pharmaceutical products through exclusive agreements, as well as operates an online B2B platform for healthcare professionals. Please visit us at https://www.hyphensgroup.com for more information.
more
28 Jan 2025 16:47Exchange-sponsored

Hyphens Pharma (HYP SP): ASEAN’S Leading Specialty Pharma Company

Hyphens Pharma (HYP SP EQUITY) is Singapore’s leading specialty pharmaceutical and consumer healthcare group, leveraging on its diverse footprints...

Logo
Kilde
277 Views
Share
14 Jun 2022 23:39

Thomson Medical (TMG SP)/Tmc Life Sciences (TMCL MK): Strong Recovery; Scale Expansion to Aid Growth

Thomson Medical, with predominant focus on gynecology and pediatrics, is well-positioned to benefit from Singapore and Malaysia re-opening. Recent...

Logo
487 Views
Share
03 Feb 2025 21:56

The Week That Was in ASEAN@Smartkarma - Alfamart's Guidance, Indonesia's Pragmatism, and Thai Banks

The past week saw insights on Sumber Alfaria Trijaya (AMRT IJ, SLB Development (SLB SP), Japfa Ltd (JAP SP), Hyphens Pharma International (HYP SP),...

Logo
383 Views
Share
15 Nov 2024 15:22Broker

Unveiling Potential Gems Within the Catalist

The Evolve Capital team is excited to begin its foray into equity research, with the ability to offer a more diverse set of offerings alongside our...

bullishHuationg Global
08 Apr 2024 10:00Exchange-sponsored

Huationg Global CEO increases interest to 7.75%

Huationg Global CEO increases interest to 7.75% Olam Group bought back a total of three million shares at S$1.13 apiece over the four sessions. Ng...

Share
x